HFS
VRTX icon

Hughes Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Hughes Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.44K Buy
19
+9
+90% +$3.99K ﹤0.01% 378
2026
Q1 		$4.46K Buy
10
+5
+100% +$2.33K ﹤0.01% 444
2025
Q4 		$2.27K Buy
5
+1
+25% +$431 ﹤0.01% 522
2025
Q3 		$1.69K Sell
4
-2
-33% -$836 ﹤0.01% 593
2025
Q2 		$2.31K Sell
6
-4
-40% -$1.84K ﹤0.01% 520
2025
Q1 		$4.85K Buy
+10
New +$4.66K ﹤0.01% 409

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Hughes Financial Services's VRTX Position: Q2 2026 in Review

Hughes Financial Services increased its Vertex Pharmaceuticals (VRTX) stake by 90% in Q2 2026, buying an estimated $3.99K and bringing the position to 19 shares worth $9.44K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Hughes Financial Services first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Hughes Financial Services held 19 shares of Vertex Pharmaceuticals worth $9.44K as of Q2 2026.
  • Hughes Financial Services bought 9 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.99K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #378 holding.
  • Hughes Financial Services first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.